Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de la Victoria (25)

2023

  1. Coronary Obstruction After Transcatheter Aortic Valve Replacement: Insights From the Spanish TAVI Registry

    JACC: Cardiovascular Interventions, Vol. 16, Núm. 10, pp. 1208-1217

  2. Iberian experience with PASCAL transcatheter edge-to-edge repair for mitral valve regurgitation

    Revista Espanola de Cardiologia, Vol. 76, Núm. 1, pp. 25-31

  3. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

  4. Transcatheter aortic valve implantation in patients with extra-small aortic annuli

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 4, pp. e340-e351

2022

  1. Early clinical outcomes after transaxillary versus transfemoral TAVI. Data from the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 75, Núm. 6, pp. 479-487

  2. Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure

    Heart (British Cardiac Society), Vol. 108, Núm. 14, pp. 1098-1106

  3. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  4. Temporal trend and potential impact of angiotensin receptor neprilysin inhibitors on transcatheter edge-to-edge mitral valve repair

    Revista Espanola de Cardiologia, Vol. 75, Núm. 12, pp. 1001-1010

2021

  1. Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation

    International Journal of Cardiology, Vol. 345, pp. 29-35

  2. Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 927-937

  3. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

    Cardiovascular Diabetology, Vol. 20, Núm. 1

  4. Percutaneous mitral valve repair: Outcome improvement with operator experience and a second-generation device

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-10

  5. Prognostic role of tapse to pasp ratio in patients undergoing mitraclip procedure

    Journal of Clinical Medicine, Vol. 10, Núm. 5, pp. 1-13

  6. ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 77, Núm. 17, pp. 2187-2199

  7. TRICENTO transcatheter heart valve for severe tricuspid regurgitation. Initial experience and mid-term follow-up

    Revista Espanola de Cardiologia, Vol. 74, Núm. 4, pp. 351-354

2020

  1. Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair

    Journal of the American College of Cardiology, Vol. 76, Núm. 21, pp. 2463-2473

  2. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  3. Transcatheter mitral repair according to the cause of mitral regurgitation: real-life data from the Spanish MitraClip registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 643-651

  4. Transcatheter mitral repair for functional mitral regurgitation according to left ventricular function: A real-life propensity-score matched study

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-14

  5. Ventricular arrhythmias in patients with functional mitral regurgitation and implantable cardiac devices: implications of mitral valve repair with Mitraclip

    ANNALS OF TRANSLATIONAL MEDICINE, Vol. 8, Núm. 15